Phenotypic screening in drug discovery has become revived While using the expectation of giving promising guide compounds and drug targets and improving the achievement charge of drug approval. Even so, focus on identification stays A significant bottleneck in phenotype-primarily based drug discovery. We recognized the lead compounds K542 and K405